Plexus Ventures Assists Celon Pharma SA with Development Strategy

Aug 17, 2017

Philadelphia, PA – Plexus Ventures, a global pharmaceutical consulting firm, announces its collaboration with Celon Pharma SA, Łomianki, Poland.

Michael O’Sullivan Managing Partner London Office, noted: “We are very pleased to provide continuing support to an important emerging company in the Polish market.”

Additional details regarding the transaction are provided in Celon’s press release:

Celon Pharma SA finalized an agreement with Plexus Ventures

2017/08/07: Under the terms of the Agreement, Plexus Ventures will develop a development strategy for drug candidates and will hold meetings with potential partners. In the event of significant clinical progress and consent of the parties to the drug development strategy, Plexus Ventures will take steps to acquire partners for development or licensees or to sell the Company’s innovative drug distribution rights. The choice of a specific strategy for the product will be related to the market and investment characteristics of the drug’s development. Licensing or selling of rights to distribution of innovative medicines Celon Pharma SA may take place at the turn of 2018/2019.

Dr. Maciej Wieczorek, President of the Management Board of Celon Pharma SA: The agreement with Plexus Ventures confirms the legitimacy of further development of selected candidates for drugs that have the potential of being the first in their therapeutic class or having significant competitive characteristics. Developed products can achieve global sales potential of more than $ 0.5 billion per year and some of them over $ 2 billion per year.

At the same time, the Company has plans for sustainable, independent commercialization of its own specialized medicines on the world markets.

About Plexus Ventures

Plexus Ventures has earned the title Business Builders in Healthcare over nearly three decades as a leading corporate and business development consultancy for healthcare industry companies. Plexus assists clients of all sizes and capabilities to achieve their strategic business development objectives. Plexus industry professionals are conveniently located in the United States, Europe and Asia-Pacific markets, enabling Plexus to benefit its clients with both local knowledge and global reach.

Trending

News

Celon Pharma enters agreement with Zydus Lifesciences Ltd.

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Celon Pharma. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal match which...